Ivabradine Effects in Cardiogenic Shock Requiring Inotropic Support

NCT05594342 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

NETWORK

Sponsor class

Conditions

Heart Failure
Cardiogenic Shock
Ischemic Heart Disease

Interventions

DRUG: Ivabradine 7.5Mg Tab
DRUG: DOBUTamine Injectable Solution

Sponsor

The Young Investigator Group of Cardiovascular Research